Search results for abx831240

Quilizumab, Abbexa, abx831240

Quilizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IGHE, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Quilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis).